Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).

× No keyword cloud information.

13 in total

1. The fall of "clinical research" and the rise of "clinical-practice research".

Authors: D L Sackett
Journal: Clin Invest Med Date: 2000-12 Impact factor: 0.825

2. Why randomized controlled trials fail but needn't: 1. Failure to gain "coal-face" commitment and to use the uncertainty principle.

Authors: D L Sackett
Journal: CMAJ Date: 2000-05-02 Impact factor: 8.262

3. Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group.

Authors: F A McAlister; S E Straus; G H Guyatt; R B Haynes
Journal: JAMA Date: 2000-06-07 Impact factor: 56.272

Review 4. The need for large-scale randomized evidence.

Authors: C Baigent
Journal: Br J Clin Pharmacol Date: 1997-04 Impact factor: 4.335

5. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found.

Authors: A S Detsky; D L Sackett
Journal: Arch Intern Med Date: 1985-04

6. Controversy in counting and attributing events in clinical trials.

Authors: D L Sackett; M Gent
Journal: N Engl J Med Date: 1979-12-27 Impact factor: 91.245

7. Why do we need some large, simple randomized trials?

Authors: S Yusuf; R Collins; R Peto
Journal: Stat Med Date: 1984 Oct-Dec Impact factor: 2.373

8. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors:
Journal: BMJ Date: 1994-01-08

9. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Authors: R Garg; S Yusuf
Journal: JAMA Date: 1995-05-10 Impact factor: 56.272

10. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

Authors: H J Barnett; D W Taylor; M Eliasziw; A J Fox; G G Ferguson; R B Haynes; R N Rankin; G P Clagett; V C Hachinski; D L Sackett; K E Thorpe; H E Meldrum; J D Spence
Journal: N Engl J Med Date: 1998-11-12 Impact factor: 91.245

24 in total

1. Managing risks: a surgeon's perspective.

Authors: Michael Gross
Journal: Can J Surg Date: 2003-04 Impact factor: 2.089

Review 2. Plea of the defence-critical comments on the interpretation of EVA3S, SPACE and ICSS.

Authors: Jens Fiehler; Søren Jacob Bakke; Andrew Clifton; Emmanuel Houdart; Olav Jansen; Daniel Rüfenacht; Michael Söderman; Christophe Cognard
Journal: Neuroradiology Date: 2010-05-04 Impact factor: 2.804

3. Controversial choice of a control intervention in a trial of ventilator therapy in ARDS: standard of care arguments in a randomised controlled trial.

Authors: H Mann
Journal: J Med Ethics Date: 2005-09 Impact factor: 2.903

10. Development of a method to compensate for signal quality variations in repeated auditory event-related potential recordings.

Authors: Antti K O Paukkunen; Miika M Leminen; Raimo Sepponen
Journal: Front Neuroeng Date: 2010-03-16

Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).